FMC · Fmc Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $758.60M | - | $542.20M | $1.05B | $791.40M | - | $1.07B | $1.04B | $918.00M | - |
| Cost of Revenue | $512.00M | - | $413.30M | $644.20M | $474.70M | - | $679.00M | $640.30M | $578.30M | - |
| Gross Profit | $246.60M | - | $128.90M | $406.30M | $316.70M | - | $386.40M | $398.10M | $339.70M | - |
| R&D | $65.50M | - | $63.30M | $66.40M | $68.70M | - | $69.00M | $75.90M | $60.90M | - |
| SG&A | $185.10M | - | $167.40M | $176.80M | $172.00M | - | $159.20M | $164.80M | $163.90M | - |
| Total Operating Expenses | $839.60M | - | $938.50M | $924.10M | $733.20M | - | $929.80M | $976.10M | $844.00M | - |
| D&A | $42.00M | - | - | - | $43.70M | - | - | - | $45.70M | - |
| Operating Income | ($81.00M) | - | ($396.30M) | $126.40M | $58.20M | - | $135.60M | $62.30M | $74.00M | - |
| Interest Expense | $64.80M | - | $64.10M | $61.00M | $61.70M | - | $58.70M | $64.50M | - | - |
| Income Tax | $112.10M | - | $82.20M | $14.40M | $13.50M | - | $6.00M | ($303.50M) | ($1.40M) | - |
| Net Income | ($281.30M) | - | ($569.30M) | $66.70M | ($15.50M) | - | $65.00M | $295.10M | ($2.70M) | - |
| EPS - Basic | ($2.25) | - | ($4.52) | $0.53 | ($0.12) | - | $0.52 | $2.35 | ($0.02) | - |
| EPS - Diluted | ($2.25) | - | ($4.52) | $0.53 | ($0.12) | - | $0.52 | $2.35 | ($0.02) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $390.90M | $584.50M | $497.70M | $438.20M | $315.30M | $357.30M | $416.70M | $471.50M | $417.80M | $302.40M |
| Accounts Receivable | $2.24B | $2.06B | $2.33B | $3.08B | $2.90B | $2.90B | $2.89B | $2.70B | $2.82B | $2.70B |
| Inventory | $1.24B | $1.22B | $1.38B | $1.40B | $1.37B | $1.20B | $1.39B | $1.44B | $1.59B | $1.72B |
| Accounts Payable | $634.10M | $771.00M | $733.60M | $906.00M | $801.80M | $768.50M | $802.90M | $697.30M | $589.30M | $602.40M |
| Current Assets | $4.90B | $4.96B | $5.57B | $5.47B | $5.08B | $4.96B | $5.32B | $5.21B | $5.20B | $5.13B |
| Total Assets | $9.42B | $9.69B | $12.08B | $12.30B | $11.80B | $11.65B | $12.22B | $12.13B | $11.98B | $11.93B |
| Current Liabilities | $3.81B | $3.76B | $3.99B | $3.57B | $3.31B | $3.02B | $3.59B | $3.52B | $3.55B | $3.38B |
| Long-term Debt | $2.77B | $2.77B | $3.27B | $3.27B | $3.03B | $3.03B | $3.03B | $3.03B | $3.02B | $3.02B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $1.82B | $2.07B | $3.77B | $4.40B | $4.38B | $4.49B | $4.61B | $4.56B | $4.31B | $4.41B |
| Retained Earnings | $3.88B | $4.17B | $5.90B | $6.54B | $6.55B | $6.64B | $6.73B | $6.73B | $6.51B | $6.59B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($600.90M) | - | - | - | ($545.00M) | - | - | - | ($142.90M) | - |
| Investing Cash Flow | ($16.20M) | - | - | - | ($38.00M) | - | - | - | ($23.70M) | - |
| Financing Cash Flow | $442.30M | - | - | - | $552.10M | - | - | - | $305.70M | - |
| CapEx | $16.60M | - | - | - | $31.60M | - | - | - | $20.70M | - |
| Free Cash Flow | ($617.50M) | - | - | - | ($576.60M) | - | - | - | ($163.60M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 32.5% | - | 23.8% | 38.7% | 40.0% | - | 36.3% | 38.3% | 37.0% | - |
| Operating margin | -10.7% | - | -73.1% | 12.0% | 7.4% | - | 12.7% | 6.0% | 8.1% | - |
| EBITDA margin | -5.1% | - | - | - | 12.9% | - | - | - | 13.0% | - |
| Net margin | -37.1% | - | -105.0% | 6.3% | -2.0% | - | 6.1% | 28.4% | -0.3% | - |
| Free cash flow margin | -81.4% | - | - | - | -72.9% | - | - | - | -17.8% | - |
| FCF / Net income | 2.20 | - | - | - | 37.20 | - | - | - | 60.59 | - |
| R&D / Revenue | 8.6% | - | 11.7% | 6.3% | 8.7% | - | 6.5% | 7.3% | 6.6% | - |
| SG&A / Revenue | 24.4% | - | 30.9% | 16.8% | 21.7% | - | 14.9% | 15.9% | 17.9% | - |
| Effective tax rate | - | - | - | 17.8% | - | - | 8.5% | - | - | - |
| Return on assets | -3.0% | - | -4.7% | 0.5% | -0.1% | - | 0.5% | 2.4% | -0.0% | - |
| Return on equity | -15.4% | - | -15.1% | 1.5% | -0.4% | - | 1.4% | 6.5% | -0.1% | - |
| Return on invested capital | -1.4% | - | -4.4% | 1.4% | 0.6% | - | 1.6% | 0.6% | 0.8% | - |
| Liquidity | ||||||||||
| Current ratio | 1.29 | 1.32 | 1.40 | 1.53 | 1.54 | 1.64 | 1.48 | 1.48 | 1.46 | 1.52 |
| Quick ratio | 0.96 | 1.00 | 1.05 | 1.14 | 1.12 | 1.24 | 1.09 | 1.07 | 1.02 | 1.01 |
| Cash ratio | 0.10 | 0.16 | 0.12 | 0.12 | 0.10 | 0.12 | 0.12 | 0.13 | 0.12 | 0.09 |
| Leverage | ||||||||||
| Debt / Equity | 1.52 | 1.34 | 0.87 | 0.74 | 0.69 | 0.67 | 0.66 | 0.66 | 0.70 | 0.69 |
| Debt / Assets | 0.29 | 0.29 | 0.27 | 0.27 | 0.26 | 0.26 | 0.25 | 0.25 | 0.25 | 0.25 |
| Debt / EBITDA | - | - | - | - | 29.71 | - | - | - | 25.27 | - |
| Interest coverage | -1.3x | - | -6.2x | 2.1x | 0.9x | - | 2.3x | 1.0x | - | - |
| Equity multiplier | 5.17 | 4.68 | 3.20 | 2.80 | 2.69 | 2.60 | 2.65 | 2.66 | 2.78 | 2.70 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.08 | - | 0.04 | 0.09 | 0.07 | - | 0.09 | 0.09 | 0.08 | - |
| Inventory turnover | 0.41 | - | 0.30 | 0.46 | 0.35 | - | 0.49 | 0.45 | 0.36 | - |
| Days sales outstanding | 1080d | - | 1569d | 1069d | 1338d | - | 990d | 950d | 1120d | - |
| Days inventory outstanding | 886d | - | 1215d | 791d | 1057d | - | 748d | 818d | 1002d | - |
| Days payable outstanding | 452d | - | 648d | 513d | 617d | - | 432d | 397d | 372d | - |
| Cash conversion cycle | 1514d | - | 2136d | 1346d | 1778d | - | 1307d | 1370d | 1750d | - |
| Valuation | ||||||||||
| P / E | - | - | - | 78.8x | - | - | 126.8x | 24.5x | - | - |
| P / B | 1.2x | - | 1.1x | 1.2x | 1.2x | - | 1.8x | 1.6x | 1.9x | - |
| P / S | 2.8x | - | 7.8x | 5.0x | 6.7x | - | 7.8x | 6.9x | 8.7x | - |
| EV / EBITDA | - | - | - | - | 78.4x | - | - | - | 88.4x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -4.1% | - | -49.1% | 1.2% | -13.8% | - | 8.5% | 2.4% | -31.7% | - |
| Revenue CAGR (3y) | -17.4% | - | -26.7% | -10.2% | -16.3% | - | -3.7% | -5.8% | -8.4% | - |
| Revenue CAGR (5y) | -8.7% | - | -12.9% | -1.9% | -8.7% | - | 1.0% | -2.9% | -5.1% | - |
| Gross profit growth (YoY) | -22.1% | - | -66.6% | 2.1% | -6.8% | - | 1.4% | -8.0% | -41.6% | - |
| Operating income growth (YoY) | - | - | - | 102.9% | -21.4% | - | 34.5% | -52.9% | -75.7% | - |
| Net income growth (YoY) | -1714.8% | - | - | -77.4% | -474.1% | - | - | 867.5% | - | - |
| EPS growth (YoY) | -1775.0% | - | - | -77.4% | -500.0% | - | - | 879.2% | - | - |
| EPS CAGR (3y) | - | - | - | -20.6% | - | - | -24.7% | 14.6% | - | - |
| EPS CAGR (5y) | - | - | - | -17.8% | - | - | -5.5% | 12.2% | - | - |
| FCF growth (YoY) | -7.1% | - | - | - | -252.4% | - | - | - | 81.8% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -58.4% | -53.8% | -18.1% | -3.6% | 1.6% | 1.7% | 40.0% | 36.0% | 24.2% | 30.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$3.47B totalInsecticides$1.57B · 45.4%
Herbicides$1.25B · 36.0%
Fungicides$362.80M · 10.5%
Plant Health$190.90M · 5.5%
Product And Service Other$94.10M · 2.7%
Geographic
$5.51B totalLatin America$1.35B · 24.5%
BR$1.12B · 20.3%
North America$1.10B · 20.0%
US$923.10M · 16.8%
EMEA$871.50M · 15.8%
Asia$142.30M · 2.6%
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing FMC CORP against the 5 most active filers in the same SIC group.
Dividends
$1.32/share trailing 12 months · -43.1% YoY
| Ex-date | Per share |
|---|---|
| Mar 31, 2026 | $0.0800 |
| Dec 31, 2025 | $0.0800 |
| Sep 30, 2025 | $0.5800 |
| Jun 30, 2025 | $0.5800 |
| Mar 31, 2025 | $0.5800 |
| Dec 31, 2024 | $0.5800 |
| Sep 30, 2024 | $0.5800 |
| Jun 28, 2024 | $0.5800 |
| Mar 27, 2024 | $0.5800 |
| Dec 28, 2023 | $0.5800 |
| Sep 28, 2023 | $0.5800 |
| Jun 29, 2023 | $0.5800 |
| Mar 30, 2023 | $0.5800 |
| Dec 29, 2022 | $0.5800 |
| Sep 29, 2022 | $0.5300 |
| Jun 29, 2022 | $0.5300 |
| Mar 30, 2022 | $0.5300 |
| Dec 30, 2021 | $0.5300 |
| Sep 29, 2021 | $0.4800 |
| Jun 29, 2021 | $0.4800 |
| Mar 30, 2021 | $0.4800 |
| Dec 30, 2020 | $0.4800 |
| Sep 29, 2020 | $0.4400 |
| Jun 29, 2020 | $0.4400 |